HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who started this subject	9/19/2000 7:35:52 AM
From: nigel bates	of 1022

Relevant ? Message 14407794 Sept. 19, 2000--Targeted Genetics Corporation (Nasdaq:TGEN - news) today announced that the Company has received notification from the U.S. Patent and Trademark Office regarding the issuance of a patent relating to its synthetic gene delivery technology. The patent, U.S. No. 6,120,794, titled ``Emulsion and micellar formulations for the delivery of biologically active substances to cells'' was issued to the University of Pittsburgh and is exclusively licensed to Targeted Genetics. The patent covers the composition and formulation of a lipid-based gene delivery system that is resistant to association with and degradation by blood components. The technology described in the patent should therefore have broad utility in the development of gene delivery systems designed to be delivered intravenously, a crucial route of delivery for the development of advanced gene delivery systems. Additionally, the formulation allows for the incorporation of other proteins, peptides or targeting elements that can be used to route the delivery system to specific cell or tissue types...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next